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Abstract
Background: The rK39 strip test is reported to be simple, sensitive, specific, non-invasive and
economical test. Since this method is supposed to be patient friendly, it may easily be accepted for
sero-epidemiological surveys. An attempt was made to evaluate the role of rK39 strip test in pre
and post treatment phases of Kala azar, as a diagnostic and prognostic marker, in addition to other
laboratory investigations, in order to evaluate its role in sero-epidemiological surveys.
Findings:  A total of 210 cases were selected for the study. One hundred clinically and
parasitologically confirmed cases were corroborated with other hematological profiles. The
formol-gel test was included along with well matched control group comprising of normal endemic
controls (50), non-endemic normals (20) and other febrile cases (40). All groups were tested by
rK39 strip test. Fifty Kala azar cases were followed up after completion of successful treatment.
They were subjected to rK39 strip test after 0, 90 and 180 days of completion of successful
treatment.
The rK39 showed sensitivity, specificity, PPV, NPV, and diagnostic accuracy of 98% (95% CI 91.7-
100), 100%, 100%, 90% (95% CI 66-100) and 98% (95% CI 92.6-100) respectively. All the 50 cured
followed up cases showed positive result by rK39 strip test even after 180 days of completion of
successful treatment.
Conclusion: The test seems an ideal qualitative test for the diagnosis of kala-azar. But for sero-
epidemiological studies the test may be used with other parameters. Alternatively a quantitative
ELISA using rK39 antigen may be used.
Background
Visceral Leishmaniasis (VL) is a potentially fatal disease,
caused by Leishmania donovani complex. The disease is
endemic in 88 countries spread over 5 continents with a
total of 12 million cases and 350 million people at risk
[1]. Of all the VL cases, more than 90% are from India,
Nepal, Bangladesh, Southern Sudan and Northeast Brazil.
In India, VL is endemic in Bihar, Eastern part of India,
Tamil Nadu, Jamu and Kashmir.
For decades, detection of the parasite has been considered
to be the definitive diagnosis of this disease. It requires
invasive procedure to detect the parasite in the tissue, i.e.
spleen, bone-marrow and lymph node. Although it is the
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gold standard for the diagnosis of VL but the procedure is
cumbersome, risky and very difficult to apply in field con-
ditions. To obviate these procedures various serological
tests have been developed, evaluated and tried. These tests
have the advantage of being safe, less invasive and can be
done in large numbers of samples. Nonspecifc methods,
such as Napier's formol gel (aldehyde test) and the Cho-
pra antimony test, which depend upon raised globulin
levels, have been used in the diagnosis of VL for several
decades. Lack of specificity, as well as varying sensitivities,
render them highly unreliable. In the past, conventional
methods of antibody detection like immunodiffusion [2],
complement fixation test [3], indirect hemagglutination
test and countercurrent immunoelectrophoresis [4] were
being used as diagnostic tool for VL. However, apart from
practical difficulties at peripheral laboratories, the sensi-
tivities and specificities of most of the above tests had
been the limiting factors. These tests are no longer in use
for routine diagnosis of VL. Indirect fluorescent antibody
test was found to be highly sensitive and specific but dif-
ficult to apply in field conditions. ELISA is a versatile test.
It is easy to apply and highly sensitive but its specificity
depends on the type of antigen used [5]. Latex agglutina-
tion test (KATEX), for the detection of leishmanial antigen
in urine of patients with VL showed high specificity but
equivocal sensitivity [6]. Direct agglutination test (DAT) is
a sensitive test and well adapted to screening of a large
population, especially using its variant referred to as, "Fast
Agglutination Screening Test". It has been advocated for
field use [7-9]. However, simple format of rK39 strip test
suggests its clear advantages for use in peripheral health
services compared to the current FD-DAT format. The
rk39 strip test is a simple, rapid and accurate test with
good sensitivity and specificity, which can be used with-
out any specific expertise. Recently, some authors have
advocated its use for the sero-epidemiological surveys
[10].
Methods
The study was carried out in Muzaffarpur district of Bihar
state, India, for comparative evaluation of the sensitivity,
specificity, predictive values (positive and negative) and
diagnostic accuracy of rK39 test. A total of 210 subjects
were investigated. The study group comprised of 100 clin-
ically, hematologically and parasitologically confirmed
patients, 50 endemic normals (mostly apparently healthy
first degree relative of patients residing in the endemic
area), 20 healthy individuals from Europe where kala-azar
is not endemic (non endemic controls) and a group of 40
individuals with history of febrile illness (tuberculosis,
malaria and enteric fever) were investigated for kala-azar.
All individuals were subjected to rK39 strip test. The cases
presented had clinical symptoms and signs suggestive of
kala-azar i.e. fever, splenomegaly and anaemia. Routine
investigations were carried out to exclude other etiologies
of the fever with hepato-splenomegaly. The final diagno-
sis of VL was established by Karnofsky score, WBC count,
hemoglobin assay, fomol-gel test and demonstration of
parasites in splenic aspirates. These patients were bled on
first encounter before and after specific treatment. All
patients were provided a standard treatment with ampho-
tericin B (Sarabhai Chemicals, Vadodara, India) in 1 mg/
kg infusions on alternate days up to a total of 15 infu-
sions.
After completion of treatment the patients were free of
symptoms. The leucocytes count restored and the formol-
gel test showed a tendency of negative reaction. Out of
100 treated Kala azar cases, 50 cases (easily accessible)
were further followed up after elaborate scrutiny, to asses
the rK39 antibodies by strip test. Approximately 5 to 6 ml
of blood was collected from each treated patient and sub-
jected to rK39 strip test for demonstration of antibodies.
Easily accessible among treated patients were monitored
every 3 months for 6 months by rK39 strip test (0, 90, &
180 days). Their case history were documented.
Formol-gel test was carried out by adding a drop of forma-
lin (40%) in two ml of serum and incubated for 20 min-
utes; a positive result was indicated by appearance of
jellification of milky white opacity.
The rK39 strip was provided by In Bios International, Inc.
562 1st Ave. South, suite 600 Seattle, WA 98104 USA. The
strip for VL assay is a qualitative membrane based immu-
noassay for the detection of antibodies to visceral leish-
maniasis in human serum. The test was conducted
according to instruction provided by manufacturers. In
brief, 20 μl serum was placed on pad. Following this, 2-3
drops of wash buffer (provided) was added to pad and the
mixture was allowed to migrate up the strip by capillary
action. The result was read within 10 minutes. There are
two pink lines in a positive result; the upper one is control
and lower one is the test. The appearance of only one pink
line means a negative result when this is upper line; but if
the one pink line is the lower line (test) this means an
invalid result.
Statistical analysis
The serological data thus obtained were statistically ana-
lyzed after entry in EPI-info (version-6) and SPSS statisti-
cal package. The Fleiss Quadratic method was used for the
calculation of confidence interval of proportions. The sen-
sitivity, specificity, predictive values (positive and nega-
tive) and diagnostic accuracy were mathematically
calculated as follows: sensitivity = (true positive/true pos-
itive + false negative) × 100; Specificity = (true negative/
true negative + false positive) × 100; Positive predictive
value (PPV) = (true positive/total positive) × 100; Nega-
tive predictive value (NPV) = (true negative/total nega-
tive) × 100; Diagnostic accuracy = (true positive + true
negative/grand total) × 100.BMC Research Notes 2009, 2:187 http://www.biomedcentral.com/1756-0500/2/187
Page 3 of 4
(page number not for citation purposes)
The study was approved by the Ethical committee of Insti-
tute of Medical Sciences, Banaras Hindu University. Writ-
ten consent was obtained from all the subjects.
Results
Of the 100 parasitologically proven index cases, 98 cases
were found to be positive for rK39 antibodies. Among the
apparently healthy endemic normals10% (5 out of 50)
showed positivity for rK39 strip test while none from non-
endemic area showed positive reaction. No cross reactivity
was found between VL cases and other febrile cases. A
detailed clinical and laboratory findings along with the
rK39 results has been depicted in the Table 1. It was
observed that the rK39 strip test had sensitivity, specifi-
city, PPV, NPV, and diagnostic accuracy of 98% (95% CI
91.7-100), 100%, 100%, 90% (95% CI 66-100) and 98%
(95% CI 92.6-100) respectively.
The rK39 strip test showed positive result in all the 50
cases after 180 days whereas formol-gel test showed 80%,
70%, and 50% positive result after 0, 90, 180 days respec-
tively (Figure 1).
Discussion
The present study was conducted on 210 subjects to eval-
uate rK39 strip test as a diagnostic and prognostic tool for
kala-azar. It showed 98% sensitivity and 100% specificity
with confirmed VL cases whereas it showed negative reac-
tion with non-endemic normals. Five subjects from an
endemic area were found to be positive by rK39 strip test.
This may be due to the fact that these persons belonged to
the same area having the same environment. The presence
of antibody in these cases may indicate either subclinical
infection or they may be during the incubation period of
the disease or they were partially treated by the local
quacks [11]. On the contrary, all the febrile cases showed
non-reactive results by this method. This result corrobo-
rates with the findings of other workers, thereby suggest-
ing that it is an ideal format for use under field conditions
as it is quick and no special equipment is needed [12,13].
On the other hand, the study conducted in Sudan showed
lower sensitivity and specificity of this test [14]. The rea-
son for this difference in sensitivity may be due to differ-
ence in antibody responses observed in different ethnic
groups [10,15]. With 98% diagnostic accuracy and 100%
PPV as observed in this study, it proves that rK39 strip test
is a good diagnostic tool qualitatively.
In the present study, fifty successfully treated individuals
were followed up for six months. All these patients
showed positive reaction by rK39 strip till 6 months. It
indicates persistence of antibodies against rK39 antigen.
This observation was supported in some studies per-
formed in successfully treated cases for the detection of
antibodies against rK39 antigen by ELISA [13,16].
In its present form, the rK39 strip test has the potential to
be used as a suitable method for diagnosis of VL. For
screening as a sero-epidemiological tool it has some
important limitations as antibody detection cannot dis-
criminate between past and current infection. Positive
result may be due to previous infection, relapse or sub-
clinical infection. It may not have relevance in predicting
the current status of the disease in an epidemiological sur-
vey. Since some authors [10] advocated the use of this test
in epidemiological surveys it may not be addressed alone.
Rather, the test may be corroborated with appropriate
clinical examination and patient interview.
Conclusion
This test used as such can only give an estimated idea
about the proportion of people that have had exposure to
leishmania parasite which eventually may suggest the
transmission dynamics of the disease that can be used for
working out the disease control strategies. An alternative
method such as semi quantitative rK39 strip test or quan-
Table 1: Clinical and laboratory features along with rK39 results of patients with visceral Leishmaniasis and Controls
Study entry
VL patients Controls
Pre-treated Post-treated (180 day)
No. 100 50 110
Age (years) 26 ± 4.5 - 27 ± 4.1
Duration of illness (months) 4.4 ± 0.45 - -
Weight (kg) 40.1 ± 6.6 45.4 ± 5.2 60 ± 5.4
Karnofsky score 71.8 ± 2.5 85.4 ± 2.7 100
Spleen size(cm) 8.4 ± 2.4 4.0 ± 0.6 -
Splenic aspirate score 2.9 ± 0.4 - -
WBC count(× 103/mm3) 3.49 ± 0.59 6.4 ± 0.6 9.1 ± 2.3
Hemoglobin (g/dL) 6.9 ± 0.48 11.2 ± 0.76 14.2 ± 2.1
Platelet count(× 103/mm3) 72 ± 0.35 270 ± 0.5 254 ± 23
rK39 positivity 98* 50* 5*
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titative ELISA with rK39 antigen may be useful for sero-
epidemiological surveys.
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Comparative evaluation of Formol-gel test and rK39 strip  test in post treated cases Figure 1
Comparative evaluation of Formol-gel test and rK39 
strip test in post treated cases.
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